Nexus Pharmaceuticals, Inc. v. US Compounding, Inc.
| US COMPOUNDING, INC. |
| NEXUS PHARMACEUTICALS, INC. |
| 21-55078 |
| February 1, 2021 |
| U.S. Court of Appeals, Ninth Circuit |
| Other Fraud |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 24, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 23 Filed order (Deputy Clerk: KS) Appellants motion to dismiss this appeal (Docket Entry No. [ # 22 ]) is granted. Fed. R. App. P. 42(b). The parties shall bear their own costs and attorneys fees on appeal. A copy of this order shall serve as and for the mandate of this cour [12525593] (JMR) [Entered: 08/24/2022 03:05 PM] |
| Filing 22 Filed (ECF) Appellant Nexus Pharmaceuticals, Inc. Stipulated Motion to dismiss case voluntarily pursuant to FRAP 42(b). Date of service: 08/12/2022. [12516388] [21-55078] (Lloyd, Neil) [Entered: 08/12/2022 05:16 PM] |
| Filing 21 Filed order MEDIATION (KS): In an order filed September 7, 2021, this appeal was administratively clo sed. The appeal is reopened. By September 12, 2022, appellant shall file either a motion or a stipulation to dismiss this matter pursuant to Fed. R. App. P. 42(b), or shall contact the Circuit Mediator. [12515759] (AF) [Entered: 08/12/2022 10:09 AM] |
| Filing 20 MEDIATION STATUS REPORT DUE - 08/09/2022. The administrative closure period is extended until 08/16/2022. At any time before that date, any party may request that this appeal be reopened. See order for details. [12473241] (CL) [Entered: 06/16/2022 02:15 PM] |
| Filing 19 Filed order MEDIATION (LW): As Circuit Mediator Chris Goelz is retiring, this case is reassigned to Circuit Mediator Kay Suk. Any status reports or questions should be sent to her directly at Kay_Suk@ca9.uscourts.gov. On or before June 15, 2022, counsel shall provide a status report by email to all counsel and Circuit Mediator (Kay_Suk@ca9.uscourts.gov). Counsel are requested to include the Ninth Circuit case name and number in the subject line. The status report should not be filed with the court. [12443938] (SB) [Entered: 05/11/2022 11:15 AM] |
| Filing 18 Filed order MEDIATION (CG): The administrative closure period is extended until June 27, 2022. At any time before that date, any party may request that this appeal be reopened. On or before June 15, 2022, counsel is requested to contact the mediator to report on the status of the case. Counsel are requested to include the Ninth Circuit case name and number in the subject line. [12422865] (SB) [Entered: 04/15/2022 02:09 PM] |
| Filing 17 Filed order MEDIATION (CG): The administrative closure period is extended until April 27, 2022. At any time before that date, any party may request that this appeal be reopened. On or before April 13, 2022, counsel is requested to contact the mediator (Chris_Goelz@ca9.uscourts.gov) to report on the status of the case. Counsel are requested to include the Ninth Circuit case name and number in the subject line. [12378782] (SB) [Entered: 02/24/2022 09:51 AM] |
| Filing 16 Filed order (Deputy Clerk: CG) This case shall continue to be held in abeyance. The Clerk is directed to temporarily close this courts docket for administrative purposes until March 9, 2022. This administrative closure is not a decision on the merits and no mandate will issue in connection with this order. At any time, any party may request that this immigration petition be reopened. On or before February 23, 2022, counsel are requested to provide the mediator with an email update. [12222299] (JMR) [Entered: 09/07/2021 04:45 PM] |
| Filing 15 Filed (ECF) Appellant Nexus Pharmaceuticals, Inc. status report (as required by Court order dated 02/25/2021). Date of service: 08/24/2021 [12210593] [21-55078] (Mock, Matthew) [Entered: 08/24/2021 05:19 PM] |
| Filing 14 Filed (ECF) Appellant Nexus Pharmaceuticals, Inc. status report (as required by Court order dated 02/25/2021). Date of service: 05/26/2021 [12124980] [21-55078] (Mock, Matthew) [Entered: 05/26/2021 09:45 AM] |
| Filing 13 Filed clerk order (Deputy Clerk: LBS): Appellants unopposed motion (Docket Entry No. [ # 12 ]) to stay appellate proceedings is granted. The previously established briefing schedule is vacated. Appellate proceedings are stayed pending resolution of Nos. 20-56158, 20-56160, and 20-56227, or until further order of the court. Appellant shall file a status report on May 26, 2021 and every 90 days thereafter while the above-mentioned cases remain pending. Appellant shall notify the court by filing a status report within 7 days of resolution of the above-mentioned cases. Failure to file a status report may terminate the stay of appellate proceedings. The briefing schedule will be reset in a future order. [12017281] (JMR) [Entered: 02/25/2021 04:53 PM] |
| Filing 12 Filed (ECF) Appellant Nexus Pharmaceuticals, Inc. Unopposed Motion to stay appellate proceedings. Date of service: 02/10/2021. [11999060] [21-55078] (Mock, Matthew) [Entered: 02/10/2021 11:06 AM] |
| Filing 11 The Mediation Questionnaire for this case was filed on 02/08/2021. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[11996941]. [21-55078] (AD) [Entered: 02/08/2021 06:44 PM] |
| Filing 10 Filed (ECF) Appellant Nexus Pharmaceuticals, Inc. Mediation Questionnaire. Date of service: 02/08/2021. [11996270] [21-55078] (Mock, Matthew) [Entered: 02/08/2021 02:10 PM] |
| Filing 9 Added Attorney(s) Imron Aly for party(s) Appellant Nexus Pharmaceuticals, Inc., in case 21-55078. [11993317] (QDL) [Entered: 02/04/2021 03:19 PM] |
| Filing 8 Filed (ECF) notice of appearance of Imron T. Aly (Schiff Hardin LLP, 233 South Wacker Drive, Suite 7100, Chicago, IL 60606) for Appellant Nexus Pharmaceuticals, Inc.. Date of service: 02/04/2021. (Party was previously proceeding with counsel.) [11993306] [21-55078] (Aly, Imron) [Entered: 02/04/2021 03:16 PM] |
| Filing 7 Added Attorney(s) Neil Lloyd for party(s) Appellant Nexus Pharmaceuticals, Inc., in case 21-55078. [11992881] (QDL) [Entered: 02/04/2021 01:06 PM] |
| Filing 6 Filed (ECF) notice of appearance of Neil Lloyd (Schiff Hardin LLP, 233 South Wacker Drive, Suite 7100, Chicago, IL 60606) for Appellant Nexus Pharmaceuticals, Inc.. Date of service: 02/04/2021. (Party was previously proceeding with counsel.) [11992731] [21-55078] (Lloyd, Neil) [Entered: 02/04/2021 11:38 AM] |
| Filing 5 Added Attorney(s) Thomas E. Hogan for party(s) Appellee US Compounding, Inc., in case 21-55078. [11992520] (QDL) [Entered: 02/04/2021 10:02 AM] |
| Filing 4 Filed (ECF) notice of appearance of Thomas Edward Hogan (Baker & Hostetler LLP, 1050 Connecticut Ave, NW, Washington, DC 20036-5304) for Appellee US Compounding, Inc.. Date of service: 02/04/2021. (Party was previously proceeding with counsel.) [11992505] [21-55078] (Hogan, Thomas) [Entered: 02/04/2021 09:56 AM] |
| Filing 3 Added Attorney(s) Bridget Springer McCabe for party(s) Appellee US Compounding, Inc., in case 21-55078. [11992460] (QDL) [Entered: 02/04/2021 09:35 AM] |
| Filing 2 Filed (ECF) notice of appearance of Bridget S. McCabe (Baker & Hostetler LLP, 11601 Wilshire Boulevard, Suite 1400, Los Angeles, CA 90025) for Appellee US Compounding, Inc.. Date of service: 02/04/2021. (Party was previously proceeding with counsel.) [11992420] [21-55078] (McCabe, Bridget) [Entered: 02/04/2021 09:23 AM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Nexus Pharmaceuticals, Inc. Mediation Questionnaire due on 02/08/2021. Appellant Nexus Pharmaceuticals, Inc. opening brief due 03/30/2021. Appellee US Compounding, Inc. answering brief due 04/29/2021. Appellant's optional reply brief is due 21 days after service of the answering brief. [11987830] (JBS) [Entered: 02/01/2021 11:02 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
